[HTML][HTML] Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim …
K Desai, P Misra, S Kher, N Shah - Experimental Hematology & Oncology, 2018 - Springer
Background Chemotherapy-induced neutropenia is a common result of myelosuppressive
chemotherapy treatment. Infections such as febrile neutropenia (FN) are sensitive to the …
chemotherapy treatment. Infections such as febrile neutropenia (FN) are sensitive to the …
[HTML][HTML] Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim …
K Desai, P Misra, S Kher… - Experimental …, 2018 - ehoonline.biomedcentral.com
Chemotherapy-induced neutropenia is a common result of myelosuppressive chemotherapy
treatment. Infections such as febrile neutropenia (FN) are sensitive to the duration of …
treatment. Infections such as febrile neutropenia (FN) are sensitive to the duration of …
Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim versus US …
K Desai, P Misra, S Kher, N Shah - Experimental Hematology & …, 2018 - europepmc.org
Background Chemotherapy-induced neutropenia is a common result of myelosuppressive
chemotherapy treatment. Infections such as febrile neutropenia (FN) are sensitive to the …
chemotherapy treatment. Infections such as febrile neutropenia (FN) are sensitive to the …
[HTML][HTML] Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim …
K Desai, P Misra, S Kher, N Shah - Experimental Hematology & …, 2018 - ncbi.nlm.nih.gov
Background Chemotherapy-induced neutropenia is a common result of myelosuppressive
chemotherapy treatment. Infections such as febrile neutropenia (FN) are sensitive to the …
chemotherapy treatment. Infections such as febrile neutropenia (FN) are sensitive to the …
Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim versus US …
K Desai, P Misra, S Kher, N Shah - Experimental Hematology & …, 2018 - go.gale.com
Background Chemotherapy-induced neutropenia is a common result of myelosuppressive
chemotherapy treatment. Infections such as febrile neutropenia (FN) are sensitive to the …
chemotherapy treatment. Infections such as febrile neutropenia (FN) are sensitive to the …
Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim versus US …
K Desai, P Misra, S Kher… - … Hematology & Oncology, 2018 - search.proquest.com
Background Chemotherapy-induced neutropenia is a common result of myelosuppressive
chemotherapy treatment. Infections such as febrile neutropenia (FN) are sensitive to the …
chemotherapy treatment. Infections such as febrile neutropenia (FN) are sensitive to the …
Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim versus US …
K Desai, P Misra, S Kher… - … hematology & oncology, 2018 - pubmed.ncbi.nlm.nih.gov
Background Chemotherapy-induced neutropenia is a common result of myelosuppressive
chemotherapy treatment. Infections such as febrile neutropenia (FN) are sensitive to the …
chemotherapy treatment. Infections such as febrile neutropenia (FN) are sensitive to the …